Retrieve available abstracts of 165 articles: HTML format
Single Articles
June 2025
GUO X, Huang C, Zhang L, Hu G, et al Lymphatic Endothelial Branched-Chain Amino Acid Catabolic Defects Undermine
Cardiac Lymphatic Integrity and Drive HFpEF.
Circulation. 2025;151:1651-1666. PubMedAbstract available
PANDEY A, Thomas T, Ji Y, Kroger B, et al TET2-Mutant Clonal Hematopoiesis Promotes Heart Failure With Preserved Ejection
Fraction.
Circulation. 2025;151:1622-1625. PubMed
FONSEKA O, Raja R, Ross C, Gare SR, et al XBP1s-EDEM2 Prevents the Onset and Development of HFpEF by Ameliorating Cardiac
Lipotoxicity.
Circulation. 2025;151:1583-1605. PubMedAbstract available
May 2025
ZHENG Y, Cao Y, Wang W, Tong Y, et al Dusp14-Mediated Dephosphorylation of MLKL Protects Against Cardiomyocyte
Necroptosis in Hypothyroidism-Induced Heart Failure.
Circulation. 2025 May 13. doi: 10.1161/CIRCULATIONAHA.125.074353. PubMedAbstract available
METRA M, Tomasoni D, Adamo M, Anker SD, et al Evidence Generation and Implementation of Transcatheter Interventions for
Atrioventricular Valvular Heart Disease in Heart Failure: Current Status and
Future Directions.
Circulation. 2025;151:1342-1363. PubMedAbstract available
MICHEL LYM, Esfahani H, De Mulder D, Verdoy R, et al An NRF2/beta3-Adrenoreceptor Axis Drives a Sustained Antioxidant and Metabolic
Rewiring Through the Pentose-Phosphate Pathway to Alleviate Cardiac Stress.
Circulation. 2025;151:1312-1328. PubMedAbstract available
April 2025
NAKAMORI S, Omori T, Fujimoto N, Ishida M, et al Interplay Between Epicardial Adipose Tissue and Left Ventricular Stiffness in
Heart Failure With Preserved Ejection Fraction.
Circulation. 2025;151:1294-1296. PubMed
KHAN SS, Breathett K, Braun LT, Chow SL, et al Risk-Based Primary Prevention of Heart Failure: A Scientific Statement From the
American Heart Association.
Circulation. 2025 Apr 16. doi: 10.1161/CIR.0000000000001307. PubMedAbstract available
BUTLER J, Usman MS, Gandotra C, Salman A, et al Patient-Reported Outcomes as End Points in Heart Failure Trials.
Circulation. 2025;151:1111-1125. PubMedAbstract available
OMLAND T, Mills NL Natriuretic Peptides for the Diagnosis of Heart Failure With Preserved Ejection
Fraction.
Circulation. 2025;151:990-992. PubMed
GLARGAARD S, Hartvig Thomsen J, Tuxen C, Lindholm MG, et al A Randomized Controlled Trial of Thoracentesis in Acute Heart Failure.
Circulation. 2025 Apr 1. doi: 10.1161/CIRCULATIONAHA.124.073521. PubMedAbstract available
March 2025
EBERLY L, Tennison A, Morgan L, Smith M, et al Centering Dine (Navajo) Voices: Barriers, Facilitators, and Perceptions of
Cardiac Care among Patients with Heart Failure in Rural Navajo Nation.
Circulation. 2025 Mar 31. doi: 10.1161/CIRCULATIONAHA.124.073166. PubMedAbstract available
KAR S, Makkar RR, Whisenant BK, Hamid N, et al Two-year Outcomes of Transcatheter Edge-to-edge Repair for Severe Tricuspid
Regurgitation: The TRILUMINATE Pivotal Randomized Trial.
Circulation. 2025 Mar 30. doi: 10.1161/CIRCULATIONAHA.125.074536. PubMedAbstract available
CHEN L, Hu Y, Saguner AM, Bauce B, et al Natural History and Clinical Outcomes of Patients With DSG2/DSC2 Variant-Related
Arrhythmogenic Right Ventricular Cardiomyopathy.
Circulation. 2025 Mar 24. doi: 10.1161/CIRCULATIONAHA.124.072226. PubMedAbstract available
HOEPER MM, Oerke B, Wissmuller M, Leuchte H, et al Correction to: Tadalafil for Treatment of Combined Postcapillary and Precapillary
Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection
Fraction: A Randomized Controlled Phase 3 Study.
Circulation. 2025;151:e763. PubMed
BASILE C, Lindberg F, Benson L, Guidetti F, et al Withdrawal of Guideline-Directed Medical Therapy in Patients With Heart Failure
and Improved Ejection Fraction.
Circulation. 2025 Mar 17. doi: 10.1161/CIRCULATIONAHA.124.072855. PubMedAbstract available
FILIPP M, Ge ZD, DeBerge M, Lantz C, et al Myeloid Fatty Acid Metabolism Activates Neighboring Hematopoietic Stem Cells to
Promote Heart Failure With Preserved Ejection Fraction.
Circulation. 2025 Mar 12. doi: 10.1161/CIRCULATIONAHA.124.070248. PubMedAbstract available
DAI H, Lu X, Zhou X Letter by Dai et al Regarding Article, "Tadalafil for Treatment of Combined
Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart
Failure and Preserved Ejection Fraction".
Circulation. 2025;151:e686. PubMed
YANCY CW Heart Failure: A Century View, From Failure to Function.
Circulation. 2025;151:585-588. PubMed
February 2025
LIU X, Wang Q, Li X, Yang Y, et al Fast Degradation of MecciRNAs by SUPV3L1/ELAC2 Provides a Novel Opportunity to
Tackle Heart Failure With Exogenous MecciRNA.
Circulation. 2025 Feb 20. doi: 10.1161/CIRCULATIONAHA.124.070840. PubMedAbstract available
BRAUMANN S, Macherey-Meyer S, Polzin A, Costard-Jackle A, et al MYSTERY-HF - Myeloperoxidase Inhibition in Patients With Heart Failure and
Reduced Ejection Fraction - a Phase II Randomized Controlled Trial.
Circulation. 2025 Feb 12. doi: 10.1161/CIRCULATIONAHA.125.074085. PubMed
SHEN L, Jhund PS, McMurray JJV Response by Shen et al to Letter Regarding Article, "Effect of
Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With
Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF".
Circulation. 2025;151:e38. PubMed
TUNCEZ A, Gurses KM Letter by Tuncez and Gurses Regarding Article, "Effect of Sacubitril/Valsartan on
Cognitive Function in Patients With Heart Failure With Preserved Ejection
Fraction: A Prespecified Analysis of PARAGON-HF".
Circulation. 2025;151:e37. PubMed
REDDY YNV, Tada A, Obokata M, Carter RE, et al Evidence-Based Application of Natriuretic Peptides in the Evaluation of Chronic
Heart Failure With Preserved Ejection Fraction in the Ambulatory Outpatient
Setting.
Circulation. 2025 Jan 22. doi: 10.1161/CIRCULATIONAHA.124.072156. PubMedAbstract available
PARK SJ, Kang DH Response by Park and Kang to Letter Regarding Article, "Ertugliflozin for
Functional Mitral Regurgitation Associated With Heart Failure: EFFORT Trial".
Circulation. 2025;151:e28. PubMed
MORDI IR, McCrimmon RJ, Lang CC SGLT Inhibitors in Persons With Heart Failure and Type 1 Diabetes: Filling the
Therapeutic Gap.
Circulation. 2025;151:199-201. PubMed
WANG J, Peng Y Letter by Wang and Peng Regarding Article, "Ertugliflozin for Functional Mitral
Regurgitation Associated With Heart Failure: EFFORT Trial".
Circulation. 2025;151:e27. PubMed
DERKS W, Rode J, Collin S, Rost F, et al A Latent Cardiomyocyte Regeneration Potential in Human Heart Disease.
Circulation. 2025;151:245-256. PubMedAbstract available
December 2024
YAMADA Y, Sadahiro T, Nakano K, Honda S, et al Cardiac Reprogramming and Gata4 Overexpression Reduce Fibrosis and Improve
Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction.
Circulation. 2024 Dec 14. doi: 10.1161/CIRCULATIONAHA.123.067504. PubMedAbstract available
DOI SN, Butt JH, Thune JJ, Nielsen JC, et al Left Ventricular Ejection Fraction and Implantable Cardioverter-Defibrillator in
Non-ischemic Heart Failure with Reduced Ejection Fraction: Insights from DANISH.
Circulation. 2024 Dec 10. doi: 10.1161/CIRCULATIONAHA.124.071777. PubMed
ALVAREZ-GARCIA J Cognitive Dysfunction in Heart Failure With Preserved Ejection Fraction:
Uncovering the Consequences of an Overlooked Comorbidity.
Circulation. 2024;150:1928-1930. PubMed
YANG X, Zhang Z Letter by Yang and Zhang Regarding Article, "Clinical Impact of Routine
Assessment of Patient-Reported Health Status in Heart Failure Clinic: The PRO-HF
Trial".
Circulation. 2024;150:e468. PubMed
SANDHU AT, Spertus JA, Heidenreich PA Reply by Sandhu et al to Letter Regarding Article, "Clinical Impact of Routine
Assessment of Patient-Reported Health Status in Heart Failure Clinic: The PRO-HF
Trial".
Circulation. 2024;150:e469-e470. PubMed
November 2024
KEHR D, Ritterhoff J, Glaser M, Jarosch L, et al S100A1ct: A Synthetic Peptide Derived From S100A1 Protein Improves Cardiac
Performance and Survival in Preclinical Heart Failure Models.
Circulation. 2024 Nov 21. doi: 10.1161/CIRCULATIONAHA.123.066961. PubMedAbstract available
JI Y, Zhang MJ, Wang W, Norby FL, et al Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac
Function in Community-Dwelling Adults: From ARIC and CHS.
Circulation. 2024 Nov 21. doi: 10.1161/CIRCULATIONAHA.124.070278. PubMedAbstract available
ZILE MR, Borlaug BA, Kramer CM, Baum SJ, et al Effects of Tirzepatide on the Clinical Trajectory of Patients with Heart Failure,
a Preserved Ejection Fraction, and Obesity.
Circulation. 2024 Nov 18. doi: 10.1161/CIRCULATIONAHA.124.072679. PubMedAbstract available
VOORRIPS SN, Westenbrink BD Ketone Treatment in Heart Failure With Preserved Ejection Fraction: Recharging
the Heart or Reducing Filling Pressures?
Circulation. 2024;150:1584-1587. PubMed
October 2024
SHEN L, Dewan P, Ferreira JP, Cunningham JW, et al Clinical Correlates and Prognostic Impact of Cognitive Dysfunction in Patients
With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF.
Circulation. 2024 Oct 21. doi: 10.1161/CIRCULATIONAHA.124.070553. PubMedAbstract available
SOHNS C, Sommer P Patients With Advanced Heart Failure and Atrial Fibrillation Deserve an Attempt
at Catheter Ablation as First-Line Therapy.
Circulation. 2024;150:1220-1222. PubMed
BEDIOUNE I, Gandon-Renard M, Dessillons M, Barthou A, et al Essential Role of the RIalpha Subunit of cAMP-Dependent Protein Kinase in Regulating
Cardiac Contractility and Heart Failure Development.
Circulation. 2024 Oct 2. doi: 10.1161/CIRCULATIONAHA.124.068858. PubMedAbstract available
JIA K, Cheng H, Ma W, Zhuang L, et al RNA Helicase DDX5 Maintains Cardiac Function by Regulating CamkIIdelta Alternative
Splicing.
Circulation. 2024;150:1121-1139. PubMedAbstract available
KNEUER JM, Grajek IA, Winkler M, Erbe S, et al Novel Long Noncoding RNA HEAT4 Affects Monocyte Subtypes, Reducing Inflammation
and Promoting Vascular Healing.
Circulation. 2024;150:1101-1120. PubMedAbstract available
September 2024
DOCHERTY KF, Henderson AD, Jhund PS, Claggett BL, et al Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart
Failure with Mildly Reduced and Preserved Ejection Fraction: a Prespecified
Analysis of The FINEARTS-HF Trial.
Circulation. 2024 Sep 29. doi: 10.1161/CIRCULATIONAHA.124.072011. PubMedAbstract available
VADUGANATHAN M, Claggett BL, Kulac IJ, Miao ZM, et al Effects of the Non-Steroidal MRA Finerenone with and without Concomitant SGLT2
Inhibitor Use in Heart Failure.
Circulation. 2024 Sep 28. doi: 10.1161/CIRCULATIONAHA.124.072055. PubMedAbstract available
SHADDY R, Burch M, Kantor PF, Solar-Yohay S, et al Sacubitril/Valsartan in Pediatric Heart Failure (PANORAMA-HF): A Randomized,
Multicenter, Double-Blind Trial.
Circulation. 2024 Sep 25. doi: 10.1161/CIRCULATIONAHA.123.066605. PubMedAbstract available
STONE GW, Lindenfeld J, Rodes-Cabau J, Anker SD, et al Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial.
Circulation. 2024 Sep 23. doi: 10.1161/CIRCULATIONAHA.124.070870. PubMedAbstract available
WANG J, Chen B, Shi Q, Ciampa G, et al Preventing Site-Specific Calpain Proteolysis of Junctophilin-2 Protects Against
Stress-Induced Excitation-Contraction Uncoupling and Heart Failure Development.
Circulation. 2024 Sep 18. doi: 10.1161/CIRCULATIONAHA.124.069329. PubMedAbstract available
Correction to: Phosphorylation-Regulated Dynamic Phase Separation of HIP-55
Protects Against Heart Failure.
Circulation. 2024;150:e268. PubMed
TANG WHW, Bakitas MA, Cheng XS, Fang JC, et al Evaluation and Management of Kidney Dysfunction in Advanced Heart Failure: A
Scientific Statement From the American Heart Association.
Circulation. 2024 Sep 10. doi: 10.1161/CIR.0000000000001273. PubMedAbstract available
KOSIBOROD MN, Petrie MC, Borlaug BA Response by Kosiborod et al to Letter Regarding Article, "Effects of Semaglutide
on Symptoms, Function, and Quality of Life in Patients With Heart Failure With
Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the
STEP-HFpEF Trial".
Circulation. 2024;150:e226-e227. PubMed
WEIR RAP Letter by Weir Regarding Article, "Effects of Semaglutide on Symptoms, Function,
and Quality of Life in Patients With Heart Failure With Preserved Ejection
Fraction and Obesity".
Circulation. 2024;150:e224-e225. PubMed
BUTT JH, McMurray JJ, Claggett BL, Jhund PS, et al Therapeutic Effects of Heart Failure Medical Therapies on Standardized Kidney
Outcomes: Comprehensive Individual Participant-Level Analysis of 6 Randomized
Clinical Trials.
Circulation. 2024 Sep 1. doi: 10.1161/CIRCULATIONAHA.124.071110. PubMedAbstract available
August 2024
SOHNS C, Moersdorf M, Marrouche NF, Bergau L, et al Catheter Ablation in Patients with End-Stage Heart Failure and Atrial
Fibrillation: Two-year Follow-up of the CASTLE-HTx Trial.
Circulation. 2024 Aug 30. doi: 10.1161/CIRCULATIONAHA.124.071517. PubMed
GOPALASINGAM N, Berg-Hansen K, Christensen KH, Ladefoged BT, et al Randomized Crossover Trial of 2-Week Ketone Ester Treatment in Patients With Type
2 Diabetes and Heart Failure With Preserved Ejection Fraction.
Circulation. 2024 Aug 20. doi: 10.1161/CIRCULATIONAHA.124.069732. PubMedAbstract available
CHATUR S, Vaduganathan M, Claggett B, Solomon SD, et al Response by Chatur et al to Letter Regarding Article, "Outpatient Worsening Among
Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the
DELIVER Trial".
Circulation. 2024;150:e107-e108. PubMed
WANG J Letter by Wang Regarding Article, "Outpatient Worsening Among Patients With
Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER
Trial".
Circulation. 2024;150:e106. PubMed
GREENE SJ, Butler J, Fonarow GC Rapid and Intensive Guideline-Directed Medical Therapy for Heart Failure: 5 Core
Principles.
Circulation. 2024;150:422-424. PubMed
NETUKA I, Tucanova Z, Ivak P, Gregor S, et al A Prospective Randomized Trial of Direct Oral Anticoagulant Therapy With a Fully
Magnetically Levitated LVAD: The DOT-HM3 Study.
Circulation. 2024;150:509-511. PubMed
TADA A, Burkhoff D, Naser JA, Harada T, et al Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart
Failure With Preserved Ejection Fraction: Insights From the Cardiac and Metabolic
Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction Trial.
Circulation. 2024 Aug 5. doi: 10.1161/CIRCULATIONAHA.124.068788. PubMedAbstract available
July 2024
ABOUMSALLEM JP, de Boer RA IGFBP7: From Senescence Biomarker to a Vaccine for Heart Failure.
Circulation. 2024;150:390-392. PubMed
WEYRICH M, Cremer S, Gerster M, Sarakpi T, et al Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney Disease.
Circulation. 2024 Jul 15. doi: 10.1161/CIRCULATIONAHA.124.069139. PubMedAbstract available
KATOH M, Nomura S, Yamada S, Ito M, et al Vaccine Therapy for Heart Failure Targeting the Inflammatory Cytokine Igfbp7.
Circulation. 2024 Jul 11. doi: 10.1161/CIRCULATIONAHA.123.064719. PubMedAbstract available
Correction to: Nitrative Modification of Caveolin-3: A Novel Mechanism of Cardiac
Insulin Resistance and a Potential Therapeutic Target against Ischemic Heart
Failure in Prediabetic Animals.
Circulation. 2024;150:e63. PubMed
June 2024
HOEPER MM, Oerke B, Wissmuller M, Leuchte H, et al Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary
Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A
Randomized Controlled Phase 3 Study.
Circulation. 2024 Jun 28. doi: 10.1161/CIRCULATIONAHA.124.069340. PubMedAbstract available
NASER JA, Tada A, Harada T, Reddy YNV, et al Effects of Dapagliflozin on Body Composition and Its Relation to Hemodynamics in
Heart Failure With Preserved Ejection Fraction.
Circulation. 2024;149:2026-2028. PubMed
DEWAN P, Shen L, Pedro Ferreira J, Jhund PS, et al Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart
Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF.
Circulation. 2024 Jun 6. doi: 10.1161/CIRCULATIONAHA.124.068774. PubMedAbstract available
May 2024
AMDANI S, Conway J, George K, Martinez HR, et al Evaluation and Management of Chronic Heart Failure in Children and Adolescents
With Congenital Heart Disease: A Scientific Statement From the American Heart
Association.
Circulation. 2024 May 29. doi: 10.1161/CIR.0000000000001245. PubMedAbstract available
JHENG JR, Bai Y, Noda K, Huot JR, et al Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in
Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction.
Circulation. 2024 May 28. doi: 10.1161/CIRCULATIONAHA.124.068624. PubMedAbstract available
CALLER T, Rotem I, Shaihov-Teper O, Lendengolts D, et al Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor
Growth.
Circulation. 2024;149:1729-1748. PubMedAbstract available
PACKER M, Anker SD, Butler J, Cleland JGF, et al Redefining Iron Deficiency in Patients With Chronic Heart Failure.
Circulation. 2024 May 11. doi: 10.1161/CIRCULATIONAHA.124.068883. PubMed
SARMA S, Dyck JRB Unlocking Pathways That Improve Cardiac Function in Chronic Heart Failure: Are
Ketones the Key?
Circulation. 2024;149:1490-1492. PubMed
KANG DH, Park SJ, Shin SH, Hwang IC, et al Ertugliflozin for Functional Mitral Regurgitation Associated With Heart Failure:
EFFORT Trial.
Circulation. 2024 May 1. doi: 10.1161/CIRCULATIONAHA.124.069144. PubMedAbstract available
April 2024
ZHANG F, Zhang L, Hu G, Chen X, et al Rectifying METTL4-Mediated N(6)-Methyladenine Excess in Mitochondrial DNA
Alleviates Heart Failure.
Circulation. 2024 Apr 30. doi: 10.1161/CIRCULATIONAHA.123.068358. PubMedAbstract available
LEMESLE G, Lamblin N, Schurtz G, Labreuche J, et al Comparison of Incidence and Prognostic Impact of Ischemic Major Bleeding and
Heart Failure Events in Patients With Chronic Coronary Syndrome: Insights From
the CORONOR Registry.
Circulation. 2024 Apr 25. doi: 10.1161/CIRCULATIONAHA.123.067938. PubMedAbstract available
SWAIN L, Bhave S, Qiao X, Reyelt L, et al Novel Role for Cardiolipin as a Target of Therapy to Mitigate Myocardial Injury
Caused by Venoarterial Extracorporeal Membrane Oxygenation.
Circulation. 2024;149:1341-1353. PubMedAbstract available
Correction to: Effects of Synchronizing Foot Strike and Cardiac Phase on Exercise
Hemodynamics in Patients With Cardiac Resynchronization Therapy: A
Within-Subjects Pilot Study to Fine-Tune Cardio-Locomotor Coupling for Heart
Failure.
Circulation. 2024;149:e1130. PubMed
LI B, Liu F, Chen X, Chen T, et al FARS2 Deficiency Causes Cardiomyopathy by Disrupting Mitochondrial Homeostasis
and the Mitochondrial Quality Control System.
Circulation. 2024;149:1268-1284. PubMedAbstract available
SANDHU AT, Calma J, Skye M, Kalwani NM, et al Clinical Impact of Routine Assessment of Patient-Reported Health Status in Heart
Failure Clinic.
Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069624. PubMedAbstract available
HERNANDEZ AF, Udell JA, Jones WS, Anker SD, et al Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial
Infarction: Insights from the EMPACT-MI Trial.
Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.124.069217. PubMedAbstract available
BREATHETT K, Lewsey S, Brownell NK, Enright K, et al Implementation Science to Achieve Equity in Heart Failure Care: A Scientific
Statement From the American Heart Association.
Circulation. 2024 Apr 3. doi: 10.1161/CIR.0000000000001231. PubMedAbstract available
Correction to: INO80-Dependent Remodeling of Transcriptional Regulatory Network
Underlies the Progression of Heart Failure.
Circulation. 2024;149:e1066. PubMed
GOKULNATH P, Spanos M, Lehmann HI, Sheng Q, et al Distinct Plasma Extracellular Vesicle Transcriptomes in Acute Decompensated Heart
Failure Subtypes: A Liquid Biopsy Approach.
Circulation. 2024;149:1147-1149. PubMed
KAPELIOS CJ, Lund LH Preemptive Versus Urgent Heart Failure Hospitalization as a Surrogate for
Mortality Risk in Heart Failure.
Circulation. 2024;149:1062-1064. PubMed
March 2024
BERG-HANSEN K, Gopalasingam N, Christensen KH, Ladefoged B, et al Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart
Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind
Trial.
Circulation. 2024 Mar 27. doi: 10.1161/CIRCULATIONAHA.123.067971. PubMedAbstract available
JESSUP M A Century of Heart Failure With Reduced Ejection Fraction: Mostly Drought,
Followed by Rapid Progress.
Circulation. 2024;149:899-901. PubMed
CLELAND JGF Nature and Magnitude of the Benefits of Dapagliflozin and Empagliflozin for Heart
Failure.
Circulation. 2024;149:839-842. PubMed
VELIKANOVA D, Poyhonen P, Lehtonen J, Simonen P, et al End-Stage Heart Failure in Cardiac Sarcoidosis.
Circulation. 2024;149:885-887. PubMed
February 2024
HOEDEMAKERS S, Pugliese NR, Stassen J, Vanoppen A, et al mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis.
Circulation. 2024 Feb 27. doi: 10.1161/CIRCULATIONAHA.123.067130. PubMedAbstract available
CRESCI S, Bach RG, Saberi S, Owens AT, et al Effect of Mavacamten in Women Compared With Men With Obstructive Hypertrophic
Cardiomyopathy: Insights From EXPLORER-HCM.
Circulation. 2024;149:498-509. PubMedAbstract available
GREEN JB, Everett BM, Ghosh A, Younes N, et al Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2
Diabetes: A Comparative Effectiveness Study).
Circulation. 2024 Feb 12. doi: 10.1161/CIRCULATIONAHA.123.066604. PubMedAbstract available
JIANG Y, Gu J, Niu X, Hu J, et al Phosphorylation-Regulated Dynamic Phase Separation of HIP-55 Protects Against
Heart Failure.
Circulation. 2024 Feb 8. doi: 10.1161/CIRCULATIONAHA.123.067519. PubMedAbstract available
SANCHEZ RH, Hamdan H, Torrealba J, Grodin JL, et al Giants Hiding in Small Places: A Case of New Onset Heart Failure,
Atrioventricular Block, and Ventricular Arrhythmias.
Circulation. 2024;149:475-480. PubMed
January 2024
HERWEG B, Sharma PS, Cano O, Ponnusamy SS, et al Arrhythmic Risk in Biventricular Pacing Compared With Left Bundle Branch Area
Pacing: Results From the I-CLAS Study.
Circulation. 2024;149:379-390. PubMedAbstract available
SUMARSONO A, Xie L, Keshvani N, Zhang C, et al Sex Disparities in Longitudinal Use and Intensification of Guideline-Directed
Medical Therapy Among Patients With Newly Diagnosed Heart Failure With Reduced
Ejection Fraction.
Circulation. 2024 Jan 23. doi: 10.1161/CIRCULATIONAHA.123.067489. PubMedAbstract available
BROMAN MT, Nadadur RD, Perez-Cervantes C, Burnicka-Turek O, et al A Genomic Link From Heart Failure to Atrial Fibrillation Risk: FOG2 Modulates a
TBX5/GATA4-Dependent Atrial Gene Regulatory Network.
Circulation. 2024 Jan 8. doi: 10.1161/CIRCULATIONAHA.123.066804. PubMedAbstract available
December 2023
REN Z, Zhao W, Li D, Yu P, et al INO80-Dependent Remodeling of Transcriptional Regulatory Network Underlies the
Progression of Heart Failure.
Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.065440. PubMedAbstract available
OSTERGAARD L, Olesen JB, Petersen JK, Nielsen LS, et al Arterial Thromboembolism in Patients With Atrial Fibrillation and
CHA(2)DS(2)-VASc 1: A Nationwide Study.
Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.066477. PubMedAbstract available
THOMPSON PD Steps May Count for More Than Just Cardiac Risk.
Circulation. 2023;148:2017-2018. PubMed
GOSS KN Preterm Birth: An Overlooked Risk Factor for Heart Failure in the Young Adult.
Circulation. 2023;148:2005-2007. PubMed
GOLDENBERG JR, Hays AG, Gabr RE, Sch?r M, et al Energetic Basis of Recovered Ejection Fraction in Human Heart Failure.
Circulation. 2023;148:1976-1978. PubMed
VAN DUIJVENBODEN S, Ramirez J, Orini M, Aung N, et al Prognostic Significance of Different Ventricular Ectopic Burdens During
Submaximal Exercise in Asymptomatic UK Biobank Subjects.
Circulation. 2023;148:1932-1944. PubMedAbstract available
MCMURRAY JJV, Docherty KF, de Boer RA, Hammarstedt A, et al Effect of Dapagliflozin Versus Placebo on Symptoms and 6-Minute Walk Distance in
Patients With Heart Failure: The DETERMINE Randomized Clinical Trials.
Circulation. 2023 Dec 7. doi: 10.1161/CIRCULATIONAHA.123.065061. PubMedAbstract available
November 2023
GREENE SJ, Butler J Expanding the Definition of Worsening Heart Failure and Recognizing the
Importance of Outpatient Escalation of Oral Diuretics.
Circulation. 2023;148:1746-1749. PubMed
WALKER MA, Chen H, Yadav A, Ritterhoff J, et al Stimulates Short-Chain Dehydrogenase/Reductase Proteins to Alleviate Heart
Failure Independent of Mitochondrial Protein Deacetylation.
Circulation. 2023 Nov 15. doi: 10.1161/CIRCULATIONAHA.123.066039. PubMedAbstract available
XU W, Billon C, Li H, Wilderman A, et al Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty
Acid Metabolism and Mitochondrial Function.
Circulation. 2023 Nov 14. doi: 10.1161/CIRCULATIONAHA.123.066542. PubMedAbstract available
WHELLAN DJ Physical Activity for Patients with Heart Failure with Reduced Ejection Fraction:
Pump up the Volume.
Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067588. PubMed
VETROVSKY T, Siranec M, Frybova T, Gant I, et al Lifestyle Walking Intervention in Patients With Heart Failure With Reduced
Ejection Fraction: The WATCHFUL Trial.
Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067395. PubMedAbstract available
KOSIBOROD MN, Verma S, Borlaug BA, Butler J, et al Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients
with Heart Failure with Preserved Ejection Fraction and Obesity: A Prespecified
Analysis of the STEP-HFpEF Trial.
Circulation. 2023 Nov 12. doi: 10.1161/CIRCULATIONAHA.123.067505. PubMedAbstract available
PATEL KV, Segar MW, Klonoff DC, Khan MS, et al Optimal Screening for Predicting and Preventing the Risk of Heart Failure Among
Adults With Diabetes Without Atherosclerotic Cardiovascular Disease: a Pooled
Cohort Analysis.
Circulation. 2023 Nov 11. doi: 10.1161/CIRCULATIONAHA.123.067530. PubMedAbstract available
KHAN SS, Coresh J, Pencina MJ, Ndumele CE, et al Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular
Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific
Statement From the American Heart Association.
Circulation. 2023 Nov 10. doi: 10.1161/CIR.0000000000001191. PubMedAbstract available
KHAN SS, Matsushita K, Sang Y, Ballew SH, et al Development and Validation of the American Heart Association Predicting Risk of
Cardiovascular Disease EVENTs (PREVENT) Equations.
Circulation. 2023 Nov 10. doi: 10.1161/CIRCULATIONAHA.123.067626. PubMedAbstract available
BAWASKAR P, Thomas N, Ismail KF, Guo Y, et al Non-ischemic or Dual Cardiomyopathy in Patients with Coronary Artery Disease.
Circulation. 2023 Nov 6. doi: 10.1161/CIRCULATIONAHA.123.067032. PubMedAbstract available
October 2023
ZAMANI SK, Sarma S, MacNamara JP, Hynan LS, et al Excess Pericardial Fat Is Related to Adverse Cardio-Mechanical Interaction in
Heart Failure With Preserved Ejection Fraction.
Circulation. 2023;148:1410-1412. PubMed
WAKEHAM DJ, Ivey E, Saland S, Lewis J, et al Effects of Synchronizing Foot Strike and Cardiac Phase on Exercise Hemodynamics
in Patients With Cardiac Resynchronization Therapy: A Within-Subjects Pilot Study
to Fine-Tune Cardio-Locomotor Coupling for Heart Failure.
Circulation. 2023 Oct 13. doi: 10.1161/CIRCULATIONAHA.123.066170. PubMedAbstract available
OSTROMINSKI JW, Vaduganathan M, Selvaraj S, Claggett BL, et al Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With
Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial.
Circulation. 2023 Oct 13. doi: 10.1161/CIRCULATIONAHA.123.065254. PubMedAbstract available
BUTT JH, Yafasova A, Doi SN, Nielsen JC, et al Implantable Cardioverter Defibrillator in Patients With Nonischemic Systolic
Heart Failure With and Without Cardiac Resynchronization Therapy: Extended
Follow-Up Study of the DANISH Trial.
Circulation. 2023;148:1179-1181. PubMed
September 2023
GODFREY S, Kirkpatrick JN, Kramer DB, Sulistio MS, et al Expanding the Paradigm for Cardiovascular Palliative Care.
Circulation. 2023;148:1039-1052. PubMedAbstract available
PARKASH R, O'Meara E, Tang ASL The Role of Ablation-Based Rhythm Control in the Tangled Web of Atrial
Fibrillation and Heart Failure.
Circulation. 2023;148:933-935. PubMed
LEBEK S, Caravia XM, Chemello F, Tan W, et al Elimination of CaMKIIdelta Autophosphorylation by CRISPR-Cas9 Base Editing Improves
Survival and Cardiac Function in Heart Failure in Mice.
Circulation. 2023 Sep 15. doi: 10.1161/CIRCULATIONAHA.123.065117. PubMedAbstract available
COCHRAN J, Yura Y, Thel MC, Doviak H, et al Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved
Ejection Fraction.
Circulation. 2023 Sep 8. doi: 10.1161/CIRCULATIONAHA.123.064170. PubMedAbstract available
CHEW DS, Li Y, Bigelow R, Cowper PA, et al Cost-Effectiveness of Vericiguat in Patients With Heart Failure With Reduced
Ejection Fraction: The VICTORIA Randomized Clinical Trial.
Circulation. 2023 Sep 6. doi: 10.1161/CIRCULATIONAHA.122.063602. PubMedAbstract available
ZHU H, Song YC, Hang PZ Letter by Zhu et al Regarding Article, "Disruption of Phosphodiesterase 3A
Binding to SERCA2 Increases SERCA2 Activity and Reduces Mortality in Mice With
Chronic Heart Failure".
Circulation. 2023;148:855-856. PubMed
ARONSEN JM, Skogestad J, Albert I, Melleby AO, et al Response by Aronsen et al to Letter Regarding Article, "Disruption of
Phosphodiesterase 3A Binding to SERCA2 Increases SERCA2 Activity and Reduces
Mortality in Mice With Chronic Heart Failure".
Circulation. 2023;148:857-858. PubMed
August 2023
HEIDENREICH P What Is a Normal Left Ventricular Ejection Fraction?
Circulation. 2023;148:750-752. PubMed
CHATUR S, Vaduganathan M, Claggett BL, Cunningham JW, et al Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection
Fraction Heart Failure in the DELIVER Trial.
Circulation. 2023 Aug 26. doi: 10.1161/CIRCULATIONAHA.123.066506. PubMedAbstract available
PACKER M, Butler J, Zeller C, Pocock SJ, et al Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or
Placebo in Patients With Heart Failure.
Circulation. 2023 Aug 24. doi: 10.1161/CIRCULATIONAHA.123.065748. PubMed
Correction to: Challenging the Hemodynamic Hypothesis in Heart Failure With
Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary
Capillary Wedge Pressure?
Circulation. 2023;148:e7. PubMed
SARMA S, Levine BD Response by Sarma and Levine to Letters Regarding Article, "Challenging the
Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is
Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?".
Circulation. 2023;148:620-621. PubMed
WUSSLER D, Belkin M, Mueller C Letter by Wussler et al Regarding Article, "Challenging the Hemodynamic
Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise
Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?".
Circulation. 2023;148:619. PubMed
RAGONE I, Barallobre-Barreiro J, Takov K, Theofilatos K, et al SERCA2a Protein Levels Are Unaltered in Human Heart Failure.
Circulation. 2023;148:613-616. PubMed
DIMOPOULOS S, Nanas S Letter by Dimopoulos and Nanas Regarding Article, "Challenging the Hemodynamic
Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise
Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?".
Circulation. 2023;148:617-618. PubMed
BORLAUG BA, Reddy YNV, Braun A, Sorimachi H, et al Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved
Ejection Fraction: The CAMEO-DAPA Trial.
Circulation. 2023 Aug 3. doi: 10.1161/CIRCULATIONAHA.123.065134. PubMedAbstract available
July 2023
PACKER M, Wilcox CS, Testani JM Critical Analysis of the Effects of SGLT2 Inhibitors on Renal Tubular Sodium,
Water and Chloride Homeostasis and Their Role in Influencing Heart Failure
Outcomes.
Circulation. 2023;148:354-372. PubMedAbstract available
MENTIAS A, Mujahid MS, Sumarsono A, Nelson RK, et al Historical Redlining, Socioeconomic Distress, and Risk of Heart Failure Among
Medicare Beneficiaries.
Circulation. 2023;148:210-219. PubMedAbstract available
WATSON WD, Green PG, Lewis AJM, Arvidsson P, et al Retained Metabolic Flexibility of the Failing Human Heart.
Circulation. 2023;148:109-123. PubMedAbstract available
GHADIMI K, Cappiello JL, Wright MC, Levy JH, et al Inhaled Epoprostenol Compared With Nitric Oxide for Right Ventricular Support
After Major Cardiac Surgery.
Circulation. 2023 Jul 4. doi: 10.1161/CIRCULATIONAHA.122.062464. PubMedAbstract available
June 2023
KONDO T, Dewan P, Anand IS, Desai AS, et al Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There
Thresholds and Inflection Points in Left Ventricular Ejection Fraction and
Thresholds Justifying a Clinical Classification?
Circulation. 2023 Jun 27. doi: 10.1161/CIRCULATIONAHA.122.063642. PubMedAbstract available
HITSUMOTO T, Tsukamoto O, Matsuoka K, Li J, et al Restoration of Cardiac Myosin Light Chain Kinase Ameliorates Systolic Dysfunction
by Reducing Superrelaxed Myosin.
Circulation. 2023;147:1902-1918. PubMedAbstract available
May 2023
TANG Y, Feng M, Su Y, Ma T, et al Jmjd4 Facilitates Pkm2 Degradation in Cardiomyocytes and Is Protective Against
Dilated Cardiomyopathy.
Circulation. 2023;147:1684-1704. PubMedAbstract available
GREENE SJ, Velazquez EJ, Anstrom KJ, Clare RM, et al Effect of Torsemide vs Furosemide on Symptoms and Quality of Life Among Patients
Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
Circulation. 2023 May 22. doi: 10.1161/CIRCULATIONAHA.123.064842. PubMedAbstract available
JANI V, Aslam MI, Fenwick AJ, Ma W, et al Right Ventricular Sarcomere Contractile Depression and the Role of Thick Filament
Activation in Human Heart Failure With Pulmonary Hypertension.
Circulation. 2023 May 17. doi: 10.1161/CIRCULATIONAHA.123.064717. PubMedAbstract available
GUPTA K, Spertus JA, Birmingham M, Gosch KL, et al Racial Differences in Quality of Life in Patients With Heart Failure Treated With
Sodium-Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the
CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials.
Circulation. 2023 May 16. doi: 10.1161/CIRCULATIONAHA.122.063263. PubMedAbstract available
SATTAR N, McMurray J, Boren J, Rawshani A, et al Years of Cardiovascular Complications and Risk Factors in Patients With Type 2
Diabetes: A Nationwide Swedish Cohort Study.
Circulation. 2023 May 8. doi: 10.1161/CIRCULATIONAHA.122.063374. PubMedAbstract available
April 2023
HUNDERTMARK MJ, Adler A, Antoniades C, Coleman R, et al Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients
With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION
Trial.
Circulation. 2023 Apr 18. doi: 10.1161/CIRCULATIONAHA.122.062021. PubMedAbstract available
BUTLER J, Talha KM, Fonarow GC STRONG-HF and Implementing Heart Failure Therapies: Godspeed ... With Care.
Circulation. 2023;147:1189-1191. PubMed
FILIPPATOS G, Ponikowski P, Farmakis D, Anker SD, et al Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric
Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An
AFFIRM-AHF Subgroup Analysis.
Circulation. 2023 Apr 13. doi: 10.1161/CIRCULATIONAHA.122.060757. PubMedAbstract available
ERN YEOH S, Docherty KF, Campbell RT, Jhund PS, et al Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection
Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF.
Circulation. 2023 Apr 11. doi: 10.1161/CIRCULATIONAHA.122.063327. PubMedAbstract available
MENTIAS A, Peterson ED, Keshvani N, Kumbhani DJ, et al Achieving Equity in Hospital Performance Assessments Using Composite
Race-Specific Measures of Risk-Standardized Readmission and Mortality Rates for
Heart Failure.
Circulation. 2023;147:1121-1133. PubMedAbstract available
Correction to: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A
Report of the American College of Cardiology/American Heart Association Joint
Committee on Clinical Practice Guidelines.
Circulation. 2023;147:e674. PubMed
BUTT JH, Solomon SD, McMurray JJV Response by Butt et al to Letter Regarding Article, "Efficacy and Safety of
Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified
Analysis of the DELIVER Trial".
Circulation. 2023;147:1119-1120. PubMed
WONG EKC, Demers C Letter by Wong and Demers Regarding Article, "Efficacy and Safety of
Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified
Analysis of the DELIVER Trial".
Circulation. 2023;147:1118. PubMed
March 2023
SACHDEV V, Sharma K, Keteyian SJ, Alcain CF, et al Supervised Exercise Training for Chronic Heart Failure With Preserved Ejection
Fraction: A Scientific Statement From the American Heart Association and American
College of Cardiology.
Circulation. 2023 Mar 21. doi: 10.1161/CIR.0000000000001122. PubMedAbstract available
SELVARAJ S, Kosiborod MN, Shah SH Response by Selvaraj et al to Letter Regarding Article, "Metabolomic Profiling of
the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction:
DEFINE-HF".
Circulation. 2023;147:922-923. PubMed
TACHIBANA S, Yu NK, Li R, Fernandez-Costa C, et al Perm1 Protects the Heart From Pressure Overload-Induced Dysfunction by Promoting
Oxidative Metabolism.
Circulation. 2023;147:916-919. PubMed
MONZO L, Melenovsky V Letter by Monzo and Melenovsky Regarding Article, "Metabolomic Profiling of the
Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction:
DEFINE-HF".
Circulation. 2023;147:920-921. PubMed
MENG Z, Zhang Z, Zhao J, Liu C, et al Nitrative Modification of Caveolin-3: A Novel Mechanism of Cardiac Insulin
Resistance and a Potential Therapeutic Target Against Ischemic Heart Failure in
Prediabetic Animals.
Circulation. 2023 Mar 8. doi: 10.1161/CIRCULATIONAHA.122.063073. PubMedAbstract available
KUEHN BM Collaborative Care Model Helps Patients With Heart Failure Meet End-of-Life
Goals.
Circulation. 2023;147:841-842. PubMed
FRIEDMAN DJ, Al-Khatib SM, Dalgaard F, Fudim M, et al Cardiac Resynchronization Therapy Improves Outcomes in Patients With
Intraventricular Conduction Delay But Not Right Bundle Branch Block: A
Patient-Level Meta-Analysis of Randomized Controlled Trials.
Circulation. 2023;147:812-823. PubMedAbstract available
SKOGESTAD J, Albert I, Hougen K, Lothe GB, et al Disruption of Phosphodiesterase 3A Binding to SERCA2 Increases SERCA2 Activity
and Reduces Mortality in Mice With Chronic Heart Failure.
Circulation. 2023 Mar 6. doi: 10.1161/CIRCULATIONAHA.121.054168. PubMedAbstract available
KONDO T, Jering KS, Borleffs CJW, de Boer RA, et al Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the
Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial.
Circulation. 2023 Mar 6. doi: 10.1161/CIRCULATIONAHA.122.062918. PubMedAbstract available
HAHN VS, Petucci C, Kim MS, Bedi KC Jr, et al Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction.
Circulation. 2023 Mar 1. doi: 10.1161/CIRCULATIONAHA.122.061846. PubMedAbstract available
February 2023
LEYVA F, Israel CW, Singh J Declining Risk of Sudden Cardiac Death in Heart Failure: Fact or Myth?
Circulation. 2023;147:759-767. PubMedAbstract available
December 2022
SHELBAYA K, Claggett B, Dorbala P, Skali H, et al Stages of Valvular Heart Disease Among Older Adults in the Community: The
Atherosclerosis Risk in Communities Study.
Circulation. 2022 Dec 16. doi: 10.1161/CIRCULATIONAHA.122.061396. PubMedAbstract available